Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators
申请人:Janssen Pharmaceutica NV
公开号:US10513523B2
公开(公告)日:2019-12-24
Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof,
Also provided herein are pharmaceutical compositions, comprising compounds of Formula (I), and methods of using compounds of Formula (I).
本文提供的是式 (I) 化合物及其药学上可接受的盐、N-氧化物或溶解物、
本文还提供了包含式(I)化合物的药物组合物,以及使用式(I)化合物的方法。